Explore the Global Artificial Pancreas Device Market — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Artificial Pancreas Device Market

Key Insight

Artificial pancreas device sales will strengthen through 2036, anchored by threshold suspend device systems at 48.9% of the product segment in 2026, driven by established regulatory clearance and widespread endocrinologist familiarity. The market was valued at USD 374.3 million in 2025 and is expected to be worth USD 937.01 million by 2036.

May 28, 2026

Anurag Sharma

250 Pages

Cite this Report

Artificial Pancreas Device Market

https://www.futuremarketinsights.com/reports/artificial-pancreas-device-system-market

License

Buy Now

Summary ToC Companies

Key Players

Abbott Laboratories
Beta Bionics Inc
BigFoot Biomedical Inc
Diabeloop
EoFlow Co. Ltd
Inreda Diabetic
Insulet Corporation
Medtronic plc
Medtronic (Ireland/USA)
Medtrum
Sequel Med Tech
Tandem Diabetes Care
Tidepool (Loop)

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Artificial Pancreas Device Market

Key Players

Similar Industry Reports